Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
16.07. | Bactiguard Holding AB: Bactiguard Holding AB's interim report second quarter 2024 | 58 | GlobeNewswire (Europe) | License revenues and EBITDA stabilizing
Second quarter 2024 (April - June)
Total revenue amounted to SEK 60.9 (51.2) million, an increase of SEK 9.7 million corresponding to 18.9%.
Net sales amounted... ► Artikel lesen | |
09.07. | BACTIGUARD HOLDING AB: Invitation to presentation of Bactiguard's interim report for the second quarter 2024 | 1 | Cision News | ||
14.05. | BACTIGUARD HOLDING AB: Bulletin from Bactiguard Holding AB's (publ) Annual General Meeting | 1 | Cision News | ||
25.04. | Bactiguard Holding AB: Bactiguard Holding AB's interim report first quarter 2024 | 129 | GlobeNewswire (Europe) | Strategic transformation concluded and new leadership in place
First quarter 2024 (January - March)
Total revenue amounted to SEK 58.8 (61.2) million, a decrease of SEK 2.4 million, corresponding... ► Artikel lesen | |
18.04. | BACTIGUARD HOLDING AB: Invitation to presentation of Bactiguard's interim report for the first quarter 2024 | 1 | Cision News | ||
12.04. | BACTIGUARD HOLDING AB: Christine Lind assumes role as CEO of Bactiguard Holding AB as of today | 2 | Cision News | ||
11.04. | BACTIGUARD HOLDING AB: Notice to attend the Annual General Meeting of Bactiguard Holding AB | 1 | Cision News | ||
11.04. | BACTIGUARD HOLDING AB: Christian Kinch assumes role as senior advisor to Bactiguard and declines re-election to the board | 1 | Cision News | ||
08.02. | Bactiguard Holding AB: Bactiguard Holding AB's year-end report 2023 | 47 | GlobeNewswire (Europe) | Stable fourth quarter marking the end of a challenging year
Fourth quarter 2023 (October - December)
Total revenues amounted to SEK 61.3 (72.2) million, a decrease of 15.0 %. Net sales amounted to... ► Artikel lesen | |
07.02. | BACTIGUARD HOLDING AB: Bactiguard appoints Christine Lind as new CEO | - | Cision News | ||
01.02. | BACTIGUARD HOLDING AB: Invitation to presentation of Bactiguard's year-end report for 2023 | 1 | Cision News | ||
14.12.23 | Bactiguard Holding AB (publ): BD to become exclusive global license partner (excluding China) for Bactiguard coated Foley catheters | 435 | PR Newswire | STOCKHOLM, Dec. 14, 2023 /PRNewswire/ -- Bactiguard Holding AB (publ.) today announces strengthened ties with leading global medical technology company Becton Dickinson & Company (BD), Bactiguard's... ► Artikel lesen | |
12.10.23 | Bactiguard Holding AB (publ): Bactiguard's coating reduces thrombo-inflammatory reactions and acute stent thrombosis - new study published | 447 | PR Newswire | STOCKHOLM, Oct. 12, 2023 /PRNewswire/ -- The medical and technology teams at Bactiguard have, together with KTH, Sweden's largest technical university (Division of Micro and Nanosystems)... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
TELADOC HEALTH | 8,562 | -0,83 % | Teladoc Health, Inc.: Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 | PURCHASE, NY, July 08, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today announced that it issued inducement awards to two new employees.... ► Artikel lesen | |
ROKU | 54,18 | -0,39 % | Why Roku Stock Was Slipping This Week | ||
SERNOVA | 0,180 | -2,60 % | Sernova beruft Jonathan Rigby in sein Board of Directors | London, Ontario; Boston, Massachusetts, den 28. Mai 2024 - Sernova Corp. (TSX: SVA) (OTCQB: SEOVF) (FWB/XETRA: PSH), ein Biotechnologieunternehmen in der
klinischen Phase, das sich auf die Entwicklung... ► Artikel lesen | |
SYNLAB | 10,960 | +0,18 % | Schock-News für Synlab Anleger vor dem Wochenende: So müssen Sie heute noch auf diese Sondermeldung reagieren! | ||
PAUL HARTMANN | 198,00 | 0,00 % | Dividendenbekanntmachungen (29.04.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) 361 DEGREES INTERNATIONAL LTD KYG884931042 0,139 HKD 0,0166 EUR ACROW LIMITED AU0000006124 0,0285 AUD 0,0174 EUR AGNC INVESTMENT... ► Artikel lesen | |
BOSTON SCIENTIFIC | 68,50 | -1,44 % | Aktie von Boston Scientific: Kurs mit wenig Bewegung (68,50 €) | Wenig Kursbewegung zur Stunde bei der Aktie von Boston Scientific . Die Aktie kostete zuletzt 68,50 Euro. Der heutige Börsentag brachte bislang wenig Kursbewegung bei dem Anteilsschein von Boston Scientific.... ► Artikel lesen | |
INVIVO THERAPEUTICS HOLDINGS | 0,200 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 23.02.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 23.02.2024.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 23.02.2024.ISIN NameCA58503M4083 MEDIVOLVE... ► Artikel lesen | |
ADDLIFE | 13,150 | -0,83 % | AddLife AB: Interim Report 1 January - 30 June 2024 | Good growth in both Business Areas and continued profitability improvement
"The companies within AddLife showed strong performance development during the quarter. In Labtech, sales growth recovered... ► Artikel lesen | |
EMBECTA | 14,400 | 0,00 % | Insulin Device Maker Embecta Weighs Sale After 70% Share Decline Following Becton Dickinson Spin-Off | ||
R1 RCM | 11,800 | -1,67 % | R1 RCM Inc.: R1 RCM Special Committee Provides Update on Evaluation of Strategic Alternatives | ||
COVETRUS | - | - | Cresilon Announces International Distribution Agreement for VETIGEL with Covetrus | Revolutionary haemostatic gel for veterinary surgeons available in UK and across Europe through Veterinary Instrumentation and distribution partners
NEW YORK, May 20, 2024 /PRNewswire/... ► Artikel lesen | |
ENOVIS | 44,200 | +2,31 % | Enovis Corporation: Enovis Announces Time Change for Second Quarter 2024 Results Conference Call | ||
SYSMEX | 14,200 | 0,00 % | Dividendenbekanntmachungen (28.03.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACOM CO LTD JP3108600002 6 JPY 0,0366 EUR ADVANEX INC JP3213400009 20 JPY 0,1222 EUR AICA KOGYO CO LTD JP3100800006 59 JPY 0... ► Artikel lesen | |
PULMONX | 7,150 | -5,30 % | Pulmonx Corporation: Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | REDWOOD CITY, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced... ► Artikel lesen | |
FRESENIUS | 31,860 | 0,00 % | Fresenius: Dank defensiver Qualitäten zum Outperformer | Die Aktie von Fresenius hat sich zuletzt als einer der Outperformer im DAX entpuppt. Charttechnisch sieht es jetzt spannend aus. Der Kurs steht direkt vor einer wichtigen Hürde und könnte mittelfristig... ► Artikel lesen |